Company / Cost of Revenue
Guardant Health, Inc. Cost of Revenue History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$349.0M
FY2025
5-year range
$227.1M / $349.0M
FY2023-FY2025
Trend
+20.4%
vs FY2024
Sector context
#70 of 107
Health Care
What the data says
At $349M, Guardant Health, Inc.'s cost of revenue ranks #38 of 107 in the Health Care sector. Increased from $227M to $349M over the past 2 years.
Based on SEC 10-K filings.
$349M in FY2025.
Increased from $227M to $349M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#38 of 107 in Health CareTop 35% of 107This company $349.0M Sector average $11.8B
▼
-97.0% below sector average
Key checks
Key Insights
- In FY2025, cost of revenue increased 20.4% year-over-year.
- Ranks #70 out of 107 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $349.0M | +20.4% |
| FY2024 | $289.8M | +27.6% |
| FY2023 | $227.1M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026